ACB
HLF icon

Aristotle Capital Boston’s Herbalife HLF Stock Holding History

Aristotle Capital Boston’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Sell
681,941
-106,647
-14% -$1.74M 0.63% 73
2025
Q4 		$10.2M Sell
788,588
-84,652
-10% -$896K 0.56% 78
2025
Q3 		$7.37M Sell
873,240
-14,019
-2% -$132K 0.38% 93
2025
Q2 		$7.65M Buy
887,259
+42,817
+5% +$318K 0.39% 85
2025
Q1 		$7.29M Sell
844,442
-185,589
-18% -$1.32M 0.36% 86
2024
Q4 		$6.89M Sell
1,030,031
-99,948
-9% -$743K 0.26% 98
2024
Q3 		$8.12M Buy
1,129,979
+8,433
+0.8% +$77.7K 0.27% 96
2024
Q2 		$11.7M Sell
1,121,546
-24,539
-2% -$245K 0.39% 86
2024
Q1 		$11.5M Sell
1,146,085
-27,511
-2% -$296K 0.35% 95
2023
Q4 		$17.9M Buy
1,173,596
+10,019
+0.9% +$138K 0.55% 78
2023
Q3 		$16.3M Buy
1,163,577
+6,187
+0.5% +$93.6K 0.52% 79
2023
Q2 		$15.3M Buy
1,157,390
+26,039
+2% +$354K 0.46% 83
2023
Q1 		$18.2M Buy
1,131,351
+61,877
+6% +$1.09M 0.56% 72
2022
Q4 		$15.9M Buy
1,069,474
+128,025
+14% +$2.23M 0.5% 81
2022
Q3 		$18.7M Sell
941,449
-83,474
-8% -$2.07M 0.63% 71
2022
Q2 		$21M Buy
1,024,923
+30,521
+3% +$755K 0.63% 70
2022
Q1 		$30.2M Sell
994,402
-22,363
-2% -$874K 0.76% 60
2021
Q4 		$41.6M Sell
1,016,765
-25,559
-2% -$1.06M 0.98% 37
2021
Q3 		$44.2M Buy
1,042,324
+102,271
+11% +$5.06M 1.04% 32
2021
Q2 		$49.6M Sell
940,053
-16,733
-2% -$832K 1.13% 25
2021
Q1 		$42.4M Sell
956,786
-48,057
-5% -$2.37M 0.94% 36
2020
Q4 		$48.3M Buy
1,004,843
+13,984
+1% +$675K 1.14% 29
2020
Q3 		$46.2M Buy
990,859
+40,646
+4% +$2M 1.34% 19
2020
Q2 		$42.7M Buy
950,213
+101,338
+12% +$3.94M 1.3% 21
2020
Q1 		$24.8M Sell
848,875
-100,520
-11% -$3.74M 1.06% 32
2019
Q4 		$45.3M Buy
949,395
+19,700
+2% +$853K 1.25% 21
2019
Q3 		$35.2M Buy
929,695
+131,666
+16% +$5.14M 1.03% 34
2019
Q2 		$34.1M Buy
798,029
+38,245
+5% +$1.81M 1.07% 30
2019
Q1 		$40.3M Buy
759,784
+417,354
+122% +$24M 1.34% 21
2018
Q4 		$20.2M Buy
342,430
+32,227
+10% +$1.78M 1.65% 9
2018
Q3 		$16.9M Buy
310,203
+18,723
+6% +$1.03M 1.24% 25
2018
Q2 		$15.7M Sell
291,480
-273,496
-48% -$14.4M 1.24% 22
2018
Q1 		$27.5M Buy
564,976
+226,668
+67% +$9.62M 1.29% 20
2017
Q4 		$11.5M Buy
338,308
+79,654
+31% +$2.79M 0.83% 52
2017
Q3 		$8.77M Buy
258,654
+41,188
+19% +$1.41M 0.79% 60
2017
Q2 		$7.76M Buy
217,466
+42,598
+24% +$1.44M 0.87% 53
2017
Q1 		$5.08M Buy
174,868
+5,164
+3% +$144K 0.68% 71
2016
Q4 		$4.08M Buy
169,704
+30,808
+22% +$841K 0.56% 82
2016
Q3 		$4.3M Buy
138,896
+8,280
+6% +$261K 0.77% 64
2016
Q2 		$3.82M Sell
130,616
-36,228
-22% -$1.08M 0.74% 68
2016
Q1 		$5.13M Buy
166,844
+9,298
+6% +$240K 1.03% 40
2015
Q4 		$4.22M Buy
157,546
+23,722
+18% +$659K 0.86% 52
2015
Q3 		$3.65M Buy
133,824
+1,714
+1% +$47K 0.89% 48
2015
Q2 		$3.64M Buy
132,110
+36,812
+39% +$891K 0.83% 53
2015
Q1 		$2.04M Buy
95,298
+35,888
+60% +$613K 0.63% 80
2014
Q4 		$1.12M Buy
+59,410
New +$1.27M 0.56% 86

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Aristotle Capital Boston's HLF Position: Q1 2026 in Review

Aristotle Capital Boston reduced its Herbalife (HLF) stake by 14% in Q1 2026, selling an estimated $1.74M and leaving 681,941 shares worth $10.1M. The position accounts for 0.63% of the portfolio, ranked #73.

Aristotle Capital Boston first reported a position in HLF in Q4 2014 and has held it in 46 quarters since. The position peaked at $49.6M in Q2 2021. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Aristotle Capital Boston held 681,941 shares of Herbalife worth $10.1M as of Q1 2026.
  • Aristotle Capital Boston sold 106,647 Herbalife shares in Q1 2026, an estimated $1.74M.
  • Herbalife made up 0.63% of Aristotle Capital Boston's portfolio in Q1 2026, its #73 holding.
  • Aristotle Capital Boston first reported a position in Herbalife in Q4 2014 and has held it in 46 quarters since.
  • Aristotle Capital Boston's Herbalife position peaked at $49.6M in Q2 2021.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Aristotle Capital Boston's 13F filing for Q1 2026, filed 15 May 2026.